Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

June 28, 2026

Study Completion Date

June 28, 2028

Conditions

Metastatic Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG

Fruquintinib in combination with Sintilimab and CAPEOX

Different doses of fruquintinib combined with sintilimab and CAPEOX

Trial Locations (1)

RECRUITING

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV